Baird’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
$2.97M Buy
83,752
+8,075
+11% +$286K 0.03% 458
2014
Q4
$2.58M Buy
75,677
+598
+0.8% +$20.4K 0.03% 485
2014
Q3
$2.9M Buy
75,079
+2,253
+3% +$86.9K 0.04% 369
2014
Q2
$2.83M Buy
72,826
+10,857
+18% +$422K 0.04% 392
2014
Q1
$2.12M Buy
61,969
+17,131
+38% +$586K 0.03% 458
2013
Q4
$941K Buy
44,838
+27,543
+159% +$578K 0.02% 631
2013
Q3
$406K Buy
17,295
+237
+1% +$5.56K 0.01% 861
2013
Q2
$458K Buy
+17,058
New +$458K 0.01% 796